Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1987 Jan;31(1):102-3.
doi: 10.1128/AAC.31.1.102.

In vitro evaluation of S-25930 and S-25932, two new quinolones, against aerobic gram-negative isolates from cancer patients

K V Rolston, D H Ho, B LeBlanc, G P Bodey
Comparative Study

In vitro evaluation of S-25930 and S-25932, two new quinolones, against aerobic gram-negative isolates from cancer patients

K V Rolston et al. Antimicrob Agents Chemother. 1987 Jan.

Abstract

The in vitro activity of S-25930 and S-25932, two new 4-quinolones, against 450 aerobic gram-negative organisms isolated from cancer patients was evaluated and compared with the activity of ciprofloxacin, enoxacin, difloxacin (A-56619), and A-56620. Both agents inhibited most members of the family Enterobacteriaceae at concentrations of less than or equal to 2.0 micrograms/ml, but their activity against Pseudomonas aeruginosa was inferior to that of other quinolones. Although considerably less active than ciprofloxacin and A-56620, S-25930 was frequently two- to eightfold more active than S-25932 and was comparable to difloxacin and enoxacin against most isolates.

PubMed Disclaimer

References

    1. Arch Intern Med. 1984 Sep;144(9):1845-51 - PubMed
    1. South Med J. 1985 Jun;78(6):647-51 - PubMed
    1. Antimicrob Agents Chemother. 1986 Jun;29(6):972-6 - PubMed
    1. Antimicrob Agents Chemother. 1985 Oct;28(4):514-20 - PubMed
    1. Rev Infect Dis. 1985 May-Jun;7(3):314-20 - PubMed

Publication types

MeSH terms